BioSpace News Archive

Business

Appointment of HSBC Bank plc as Joint Corporate Broker in London

Hutchison China MediTech Limited today announces that it has appointed HSBC Bank plc as its joint Corporate Broker in London with immediate effect.

October 9, 2018
·
2 min read
Business

Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE® (palbociclib) and talazoparib in Combination with CB-839

Phase 1/2 trials expected to initiate 1Q2019

October 9, 2018
·
5 min read
Policy

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. (TGTX) and Encourages TGTX Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired TG Therapeutics, Inc. securities from June 4, 2018 through September 25, 2018

October 9, 2018
·
2 min read
Drug Development

Retrophin to Present Long-Term Data from Phase 2 DUET Study of Sparsentan in FSGS at ASN Kidney Week 2018

Retrophin, Inc. today announced that it will present new data examining the long-term effects of sparsentan in focal segmental glomerulosclerosis (FSGS), at the American Society of Nephrology (ASN) Kidney Week 2018.

October 9, 2018
·
6 min read
2018 World Cancer Congress in Southeast Asia mobilises over 2,500 experts in public health to discuss cancer control

From 1-4 October, more than 2,500 public health experts from over 120 countries convened in Kuala Lumpur at the 2018 World Cancer Congress (WCC).

October 9, 2018
·
10 min read
Business

Aglaris Appoints New CEO to Drive Commercialisation of Ground-breaking Cell-based Therapy Manufacturing System

Aglaris Ltd. today announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately.

October 9, 2018
·
3 min read
Bio NC

EpiCypher SNAP-ChIP® technology poised to transform market for histone PTM antibodies

A recently published report in Molecular Cell validates the use of EpiCypher’s proprietary SNAP-ChIP® technology for profiling antibody specificity and sensitivity.

October 9, 2018
·
1 min read
Drug Development

Patient Death and Life-Threatening Side Effects Cause Affimed to Hold Phase I Cancer Trials

Affimed, based in Heidelberg, Germany, placed a clinical hold on its two AFM11 Phase I clinical trials. AFM11 is being evaluated in the trials for relapsed or refractory CD19 positive B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.

October 9, 2018
·
2 min read
·
Mark Terry
FDA

Four Life Science Companies Make Time’s Genius List

In looking at companies that are shaping the future, Time Magazine selected 50 business that are leading the charge. While many tech companies lead the way, there are several pharma and life science companies that are also disrupting the future.

October 9, 2018
·
2 min read
·
Alex Keown
Drug Development

Stellar Phase III Data from Janssen’s Stelara

New late-stage data released by Janssen shows that a single dose of Stelara can induce clinical reemission and response in adult patients with moderate to severe ulcerative colitis who have not had positive response from previous treatment options.

October 9, 2018
·
3 min read
·
Alex Keown